Anal intraepithelial neoplasia (AIN) is a premalignant lesion for anal cancer, which is steadily increasing. AIN development is driven by HPV infection, and its incidence is skewed both by pre-existing conditions and in high-risk populations.
This webinar presents our latest understanding on screening, surveillance, and treatment for AIN.
The ANCHOR Trial Results and Where We Go From Here
Dr Stephen GOLDSTONE
Assistant Clinical Professor, Surgery, Icahn School of Medicine at Mount Sinai, New York, New York USA
Challenging Cases of AIN: Case Presentation
Dr Andrew Tin Yau WONG
Specialist in Infectious Disease
Hon. Consultant, Infectious Disease Centre and Department of Medicine & Geriatrics, Princess Margaret Hospital, Hong Kong
Q&A session
Moderated by
Dr Andrew Tin Yau WONG
Accreditation
Accreditors | Points (Max) | Group / Category |
College of Obstetricians & Gynaecologists | Pending | |
Hong Kong College of Community Medicine | 1 | PP |
Hong Kong College of Paediatricians | 1 | E |
Hong Kong College of Pathologists | 1 | PP |
Hong Kong College of Physicians | 1 | PP |
Hong Kong College of Radiologists | 1 | B |
The College of Surgeons of Hong Kong | 1.5 | |
The Hong Kong College of Anaesthesiologists | 1.5 | |
The Hong Kong College of Family Physicians | Pending | |
The Hong Kong College of Otorhinolaryngologists | 0.5 | Cat 2.2 |
The Hong Kong Medical Association (MCHK CME) | 1 | Passive |
Notes
- This webinar is open to all healthcare professionals and is conducted in English.
- The webinar will be held via Zoom. Login details will be emailed to you in 5 minutes when you register online.
- CME application is in progress, details of which will be posted on this webpage in due course. To facilitate CME registration, please register with your FULL NAME and show your registered name during the webinar.
Enquiry: +852 3893 6222 (WhatsApp message/call)
Supported by